Gewandter Team News
Accomplishments
October 22nd, 2024
Valerie Chiodo Receives 2024 SCORE Study Coordinator Mentorship Award
This Award is in recognition of her commitment to Mentorship values of an individual who demonstrates a willingness to share her knowledge, skills and time with others as well as encouraging the mentees to gain confidence in their skills and develop professionally.
Rachel De Guzman Receives CCRC Credential
The Certified Clinical Research Coordinator credential formally recognizes clinical research professionals with experience coordinating and facilitating clinical trial activities in adherence to GCP, under the direction of a principal investigator.
October 7th, 2024
Dr. Gewandter and Her Mentees, Dr. Karim Saab and Mr. Umang Gada, Publish an Article in Pain Medicine
The article proposes that personalized outcomes may provide a more clinically relevant estimate of treatment effects in neuropathic pain clinical trials.
Dr. Karim Saab
It uses data from Dr. Gewandter’s recently completed clinical trial to demonstrate how personalized outcomes can minimize the floor effect that can occur when using composite outcomes that include domains that not all participants experience.
Dr. Gewandter Invited to Serve on NIH HEAL Advisory Committee
Dr. Jennifer Gewandter has been invited to serve on a NIH HEAL advisory committee to develop research priorities for the “optimization of existing and novel interventions to improve pain management.”
The committee’s recommendations will be used to inform the next HEAL strategic plan.
August 1st, 2024
Dr. Gewandter and Her Mentees, Maddy Rangel and Soroush Besharat, Published in The Journal of Pain
This article suggests that using daily means of worst pain qualities to define entry criteria and outcome measures in clinical trials improves assay sensitivity when compared to single ratings asking participants to rate their pain qualities over the past week. These data are important to justify the increased burden of daily pain quality ratings in clinical trials.
Left to Right: Maddy Rangel, Soroush Besharat and Dr. Gewandter
Rangel M, Besharat S, Sohn MB, Foust M, Francar L, Jorgensen C, Mustian K, Morrow G, Culakova E, Jensen MP, Langford D, Gewandter JS. Mean of daily vs. single week recall-based pain quality assessments in neuropathic pain trials: Implications for assay sensitivity. The Journal of Pain, Epub ahead of print.
https://pubmed.ncbi.nlm.nih.gov/39067580/
July 17th, 2024
Dr. Gewandter invited to serve on the advisory board of the NIH PURPOSE Network
The mission of the PURPOSE (Positively Uniting Researchers of Pain to Opine, Synthesize, & Engage) Network is the promote communication and collaboration among pain researchers throughout the United States with a priority of fostering success of junior researchers.
Dr. Gewandter brings her years of experience and passion related to promoting junior faculty advancement and mentorship to the advisory board.
July 10th, 2024
Dr. Gewandter Receieves UR-Star for Respect
Congratulations Jennifer Gewandter! She received a UR Star-ICARE Values for Respect from Suzanne Landy who wrote:
"When you work with a faculty member who exhibits pure kindness and gratitude on a daily basis, it is an absolute pleasure. Dr. Gewandter, no matter the task, treats all staff with a tremendous amount of Compassion and Respect. Each time ORPA helps her, she is patient and kind. She understands that ORPA is doing the best they can so that she can be the most successful in her position, but never loses sight of treating others with respect, even if it is a challenging task. Thank you!"
July 8th, 2024
Pain Treatment Center Research Team publishes in RAPM
This large, prospective study is the best evidence in the literature to suggest that administering steroids immediately after radiofrequency ablation does not decrease post-procedural pain. The study was led by Drs. Williams, Philip, and Gewandter. It would not have been possible without many co-investigators in the department and the efforts of the Anesthesiology Clinical Research Center (see full author list in citation below).
Mark R. Williams, MD, Annie Philip, MBBS, Soun Sheen, MD, Saumya Aujla, MD, Changyong Feng, PhD, Shan Gao, MS, Sarah Kralovic, MD, Joseph Poli, MD, Tammy Ortiz, Tatsiana Stefanos, RN, Janet Pennella-Vaughan, MS, NP, Jennifer S. Gewandter, PhD, MPH. Non-Inferiority study assessing the utility of post cervical and lumbar radiofrequency ablation steroid use. Regional Anesthesia and Pain Medicine. In Press.
April 4th, 2024
Dr. Saab receives travel award to attend the 2024 United States Association for the Study of Pain Annual Scientific Meeting in Seattle.
March 15th, 2024
Dr. Karim Saab receives a travel award to attend the second annual PURPOSE (Positively Uniting Researchers of Pain to Opine, Synthesize, & Engage) meeting in National Harbor, MD.
Three mentees to represent Dr. Gewandter’s team at the upcoming annual meeting of the United States Association for the Study of Pain (USASP) in Seattle, WA
Soroush Besharat, MD (URMC Anesthesia resident), Madelaine Rangel, BS (URMC medical student) and Karim Saab, MD (URMC Anesthesia Postdoc fellow) will be presenting the posters listed below. Dr. Saab was also invited to give an oral presentation on his abstract at the USASP Clinical Trials Special Interest group meeting.
“Personalized Trial Outcomes for Painful Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Strategy to Increase Assay Sensitivity”
“Mean of Daily vs. Single Week Recall-Based Pain Quality Assessments in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN) Trials: Implications for Assay Sensitivity.”
URMC Anesthesia residents, Remington Mark, MD and Mahd Nishtar, MD, publish an article in RAPM with Dr. Gewandter.
Additional residents who contributed to this work include Fallon O. France and Meghan Park
Nishtar M, Mark R, Langford DJ, McDermott MP, Markman JD, Evans SR, France FO, Park M, Sharma S, Turk DC, Dworkin RH, Gewandter JS. Evaluating the balance of benefits and harms in chronic pain clinical trials: prioritizing individual participants over individual outcomes. RAPM, 2023, epub ahead of print.
Robert Knoerl, PhD (Assistant Professor, University of Michigan) publishes article that explores analgesic use patterns among cancer survivors with chronic chemotherapy-induced neurotoxicity.
Knoerl R, Sohn MB, Foust M, Francar L, O’Rourke MA, Morrow G, Mustian K, Gauthier L, Gewandter JS. Exploring Analgesic Use Patterns among Cancer Survivors with Chronic Chemotherapy-Induced Neurotoxicity. Oncology Nursing Forum.
Dr. Gewandter Featured on "Hysteria and Her" Podcast
https://open.spotify.com/episode/0spLSbMYIzQ84PGLZmk2iH?si=X_P53aGdTSCKkknao65Mbw
March 4th, 2024
Dr. Gewandter Visiting Professor and Johns Hopkins Blaustein Pain Grand Rounds Lecturer
Jennifer Gewandter, Phd, MPH of the Department of Anesthesiology and Perioperative Medicine has been selected as 2024 Visiting Professor and Johns Hopkins Blaustein Pain Treatment Center Grand Rounds lecturer.
The title of her presentation will be “Chronic pain clinical trials: Balancing theory and practice.”
Passcode:Ks!ST1q#
Jennifer Gewandter, PhD, MPH Invited to Speak at International Association for the Study of Pain World Congress
Dr. Gewandter has been selected to speak at the International Association for the Study of Pain (IASP) 2024 World Congress in Amsterdam.
She will be the chair of a 3-speaker session: “Personalized and Multidimensional Outcomes for Pain to Improve Clinical Meaning and Sensitivity.” Her talk will be entitled “Personalized outcomes for neuropathic pain trials: A participant-centered approach.”
February 29th, 2024
Dr. Gewandter Invited to Serve as Faculty at NIH Network Meeting
Dr. Gewandter has been invited to serve as faculty at the 2nd annual NIH-sponsored PURPOSE (Positively Uniting Researchers of Pain to Opine, Synthesize, & Engage) Network meeting aimed at helping to advance the careers of Junior researchers.
Dr. Gewandter will speak about her perspectives on publishing and editing in the pain field and will serve on a panel of K24 awardees discussing their experience with the grant mechanism
Jennifer Gewandter, PhD, MPH Accepted Into United States Association for the Study of Pain Leadership Academy
Dr. Gewandter is one of 11 mid-career pain researchers in the country to be accepted to the first annual United States Association for the Study of Pain Leadership Academy.